Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVT
Neutrophil-specific integrin α9 deficiency results in a significant reduction in poststroke DVT severity.Macitentan is a potent inhibitor of integrin α9/VC